Salicylic acid

Description

Corn Remover Pads are designed for the effective treatment of corns. These pads provide a targeted approach to alleviate discomfort associated with corns by utilizing a medicated formula. The pads are typically composed of a soft, flexible material that conforms to the contours of the foot, ensuring a secure fit. Each pad is infused with active ingredients that facilitate the removal of corns while protecting the surrounding skin. The product is intended for external use only and is available in various sizes to accommodate different corn types and locations.

Uses and Indications

This drug is indicated for the treatment of corns. Patients should wash the affected area and dry it thoroughly before application. The medicated round part of the patch should be placed firmly over the center of the corn, with the adhesive side next to the skin. If necessary, the medicated patch may be cut to fit the corn appropriately.

Treatment may be repeated daily as needed for up to 14 days, or until the corn is removed. To enhance the effectiveness of the treatment, patients may soak the corn in warm water for 5 minutes prior to application.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Each patient should apply one patch per day. Each patch contains 1 mg of the active ingredient, tollgate. The patch should be applied to a clean, dry area of the skin, ensuring that it is pressed firmly in place to ensure proper adhesion. It is recommended to rotate the application site to minimize skin irritation. The patch should be removed after 24 hours, and a new patch can be applied to a different site. Care should be taken to avoid reapplying to the same site within a week.

Contraindications

Use of this product is contraindicated in patients with poor blood circulation due to the potential for exacerbating vascular issues. It is also contraindicated in individuals who are diabetic, pregnant, or breastfeeding, as these conditions may pose additional risks. Application on irritated skin or any area that is infected or reddened is not recommended, as this may lead to further irritation or complications.

Warnings and Precautions

For external use only. This product is not intended for internal use and should be applied strictly as directed.

It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse.

Caution is advised for individuals with poor blood circulation, as the use of this product may exacerbate existing conditions. Additionally, it is contraindicated for use in individuals who are diabetic, pregnant, or breastfeeding due to potential risks associated with these conditions.

The product should not be applied to irritated skin or any area that is infected or reddened, as this may lead to further complications or adverse reactions.

In the event that discomfort persists following application, it is recommended that the individual consult a healthcare professional, such as a doctor or podiatrist, for further evaluation and guidance.

Side Effects

For external use only. Patients should be advised that if discomfort persists, they should consult their doctor or podiatrist.

Drug Interactions

No drug interactions have been identified for this product. Additionally, there are no reported interactions with laboratory tests. Therefore, no specific dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Corn Remover Pads. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. It is essential to ensure that the medication is stored safely to prevent accidental ingestion or misuse by young children.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients with diabetes should be closely monitored due to the potential risks associated with hyperglycemia and its impact on fetal outcomes. It is essential for healthcare providers to assess the management of diabetes during pregnancy to minimize complications for both the mother and the fetus. Additionally, breastfeeding considerations should be taken into account, as the safety of the medication during lactation has not been established. Women of childbearing potential should be advised on the importance of effective contraception while on this medication to prevent unintended pregnancy and associated risks.

Lactation

Lactating mothers should be aware that the use of this medication may have implications for breastfeeding. There is limited data available regarding the excretion of this medication in human breast milk. Therefore, healthcare professionals should carefully consider the potential risks and benefits when prescribing this medication to lactating mothers.

Breastfed infants may be affected by the medication, and monitoring for any adverse effects is recommended. It is essential for lactating mothers to consult with their healthcare provider to discuss their specific situation, especially if they have underlying conditions such as diabetes or pregnancy.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no information available regarding overdosage for this product. Healthcare professionals are advised to monitor patients closely for any adverse effects and to follow standard protocols for managing potential overdose situations. In the absence of specific data, it is recommended that clinicians exercise caution and consider supportive care as necessary. If an overdose is suspected, immediate medical attention should be sought, and symptomatic treatment should be initiated based on the patient's clinical presentation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to inform them if they have poor blood circulation, as this may affect the suitability of the treatment. It is also important to discuss any existing conditions such as diabetes, pregnancy, or breastfeeding, as these factors may require special consideration or adjustments in therapy.

Patients should be cautioned against using the treatment on irritated skin or on any area that is infected or reddened. This is crucial to prevent exacerbation of the condition or potential complications.

Additionally, healthcare providers should instruct patients to seek medical advice from their doctor or podiatrist if discomfort persists after using the treatment. This ensures that any underlying issues are addressed promptly and appropriately.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 59°F to 86°F (15°C to 30°C) to maintain its efficacy and stability. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable container that protects it from environmental factors. Special handling requirements should be observed to prevent any compromise to the product's integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Corn Remover Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)